OCS 股價走勢圖
OCS 股票價格預測
Oculis Holding AG
$13.12
1.46%
$0.18
收盤價：Jul 15, 16:00:00 GMT-4
$12.9
-1.67%
$-0.21
盤後：Jul 15, 20:00:00 GMT-4
返回
Oculis Holding AG (OCS) 股票價格預測
關鍵數據
前收市價
$12.93
開盤價
$12.84
當日範圍
$12.69 - $13.22
52週區間
$10.52 - $34.47
交易量
222.7K
平均成交量
576.7K
股息收益率
--
每股盈餘 (TTM)
-1.72
市值
$800.3M
什麼是 OCS？
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 60 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
